Evidence map›Paper›PMID 36437866›Full record

ArticleWorld journal of diabetes2022

Risk factor analysis and clinical decision tree model construction for diabetic retinopathy in Western China.

Yuan-Yuan Zhou, Tai-Cheng Zhou, Nan Chen, Guo-Zhong Zhou, Hong-Jian Zhou, Xing-Dong Li, Jin-Rui Wang, Chao-Fang Bai, Rong Long, Yu-Xin Xiong and 1 more

Open access · diamondAbstract read
In one paragraph

Article in World journal of diabetes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Yuan-Yuan ZhouDepartment of Endocrinology and Metabolism, The Sixth Affiliated Hospital of Kunming Medical University, The People's Hospital of Yuxi City, Yuxi 653100, Yunnan Province, China.
Tai-Cheng ZhouDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China.
Nan ChenDepartment of Endocrinology and Metabolism, The Frist People's Hospital of Anning City, Anning City 650300, Yunnan Province, China.
Guo-Zhong ZhouDepartment of Endocrinology and Metabolism, The Frist People's Hospital of Anning City, Anning City 650300, Yunnan Province, China.
Hong-Jian ZhouDepartment of Endocrinology and Metabolism, The Sixth Affiliated Hospital of Kunming Medical University, The People's Hospital of Yuxi City, Yuxi 653100, Yunnan Province, China.
Xing-Dong LiDepartment of Endocrinology and Metabolism, The Sixth Affiliated Hospital of Kunming Medical University, The People's Hospital of Yuxi City, Yuxi 653100, Yunnan Province, China.
Jin-Rui WangDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China.
Chao-Fang BaiDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China.
Rong LongDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China.
Yu-Xin XiongDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China.
Ying YangDepartment of Endocrinology and Metabolism, Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming 650021, Yunnan Province, China. yangying2072@126.com.
Second People's Hospital of Yunnan Province · CNKunming Medical University · CNOspedale Sant'Anna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy (DR) is the driving force of blindness in patients with type 2 diabetes mellitus (T2DM). DR has a high prevalence and lacks effective therapeutic strategies, underscoring the need for early prevention and treatment. Yunnan province, located in the southwest plateau of China, has a high pre-valence of DR and an underdeveloped economy.

aimTo build a clinical prediction model that will enable early prevention and treatment of DR.

methodsIn this cross-sectional study, 1654 Han population with T2DM were divided into groups without (

resultsDiabetes duration ≥ 10 years, female sex, standing- or supine systolic blood pressure (SBP) ≥ 140 mmHg, and cholesterol ≥ 6.22 mmol/L were risk factors for DR in logistic regression analysis (odds ratio = 2.118, 1.520, 1.417, 1.881, and 1.591, respectively). A greater severity of chronic kidney disease (CKD) or hemoglobin A 1c increased the risk of DR in patients with T2DM. In the decision tree model, diabetes duration was the primary risk factor affecting the occurrence of DR in patients with T2DM, followed by CKD stage, supine SBP, standing SBP, and body mass index (BMI). DR classification outcomes were obtained by evaluating standing SBP or BMI according to the CKD stage for diabetes duration < 10 years and by evaluating CKD stage according to the supine SBP for diabetes duration ≥ 10 years.

conclusionBased on the simple and intuitive decision tree model constructed in this study, DR classification outcomes were easily obtained by evaluating diabetes duration, CKD stage, supine or standing SBP, and BMI.

Indexed as

Decision treeDiabetic retinopathyType 2 diabetesWestern China

Identifiers

PMID36437866
PMCPMC9693737
OpenAlexW4308866282

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.